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SUMMARY 
A case of?, young manic patient who developed severe neurotoxicity when on lithium alone has been 
presented. Investigations did not reveal presence of any infection, electrolyte imbalance or rise in lithium level. 
The possibility of lithium producing neurotoxicity at therapeutic levels for as yet unknown reasons 
is pointed out. It is suggested that this element of risk be considered when starting lithium for therapy or 
prophylaxis of affective disorders. 
Generally, serum levels of 1.0 to 1.5 
m Eq/L have been recommended for the 
treatment of acute mania, and levels of 0.8 
to 1.0 m Eq/L for the prophyalxis of affective 
disorders. Severe intoxication is unusual 
at serum levels <3.0 m Eq/L and levels 
^ 5.0 m Eq/L can be fatal (Strayhorn 
and Nash, 1977). 
Lithium intoxication at therapeutic 
serum levels, although rare, is not un-
known. Strayhorn and Nash (1977) have 
reviewed the relevant literature and dis-
cussed the possible explanations, namely : 
(i) synergistic action of lithium with other 
drugs, (ii) excessive tissue retention of 
lithium, (iii) loss of sodium through di-
uretic therapy or dehydration, (iv) old age 
and infirmity of the patient, (v) a seizure 
diathesis in the patient, (vi) use of lithium 
to treat schizophrenia and (vii) concurrent 
infections. 
We present here the case report of a 
young male manic depressive who developed 
severe neurotoxicity at "therapeutic" serum 
level of lithium and in whom the afore-
mentioned "explanations" did not seem 
to apply. 
REPORT 
Mr. P. aged 22 yrs. had been having 
manic depressive attacks since February 
1976. On all occasions he was treated at 
NIMHANS. 
The course of the illness was as follows ; 
In February 1976, he had a short spell of 
depression (nearly three weeks) followed 
by a manic episode of 14 weeks duration. 
He was treated with Haloperidol 15-40 
mg per day. He had 2 manic episodes in 
April 1977, and September 1977, of nearly 
2 months each, and was treated with halo-
peridol (20 mg) and Chlorpromazine (400-
800 mg) per day. In March 1978 he had 
an episode of mania followed by a short 
depressive spell ; both episodes together 
lasting nearly 3 months. He was treated 
first with haloperidol (10-30 mg per day) 
and later with imipramine (150 mg/day) 
till discharge. 
On 12th November 1978, he was 
admitted for the 5th attack of mania. As 
the episodes of affective illness were be-
coming very frequent, we decided to start 
him on lithium. After initial blood urea, 
serum creatinine estimations, urine micro-
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scopy and EKG, he was started on lithium 
carbonate 900 to 1350 mg per day, with a 
serum level of between 0.8 and 1.1 m Eq/L. 
At no time was the standard serum lithium 
level (12 hours after last dose of lithium 
carbonate) over 1.1m Eq/L. He improved 
remarkably and was discharged on 16th 
December 1978 on lithium carbonate at 
1050 mg per day (Lithocarb 150 mg-2-2-3). 
He was euthymic and in good health at 
the time of discharge. 
He was seen again on 3rd January 
1979 when he was euthymic, quite healthy, 
had only mild tremor of hands. He was 
advised to continue the same treatment 
and to report for serum lithium estimation 
after 2 weeks. 
He was brought to the outpatient de-
partment on 8.1.1979 with complaints of 
severe tremors, dizziness, feelings of marked 
weakness and feeling sleepy. 
On examination, he was found to be 
drowsy, slightly confused and irritable, 
with definite memory deficits. There was 
marked tremor of the hands and the speech 
was dysarthric. Temperature was 37.2°C, 
there was no dehydration, pulse was 92/min. 
regular, and blood pressure was 126/84 mm 
of mercury. Cardiovascular and respira-
tory systems were normal. 
Nervous system examination revealed 
dysarthric speech, severe tremor of the 
hands, moderate weakness (Grade III) 
with hypotonia of all the four limbs. There 
was mild ataxia and nystagmus. Cere-
bellar signs were minimal. Reflexes were 
symmetrically diminished in all the four 
limbs. Plantars were flexor. There were 
no signs of meningeal irritation. 
He was admitted with a diagnosis of 
possible lithium toxicity. 
Emergency estimation of serum elec-
trolytes revealed—lithium 1.0 mEq/L (11 
hrs. after last dose), Sodium 142 mEq/L, 
Potassium 3.7 mEq/L, Chloride 100 m 
Eq/L. Hemogram results were as follows : 
WBC total count=4900/cu mm. differential 
count=Polys —66 %, Lymphocytes=26 %, 
Eosinophils=4%, and Monocytes =4%, 
ESR=8 mm/hr. E.K.G. and Chest X-rays 
were normal. A repeat serum lithium 
within one hour was also I m Eq/L. 
A lumbar puncture was then per-
formed to exclude encephalitis. The C.S.F. 
was normal : clear, colourless fluid, cells 
2/ cu mm. (Lymphocytes), Protein 26 mg%, 
Globulin negative, Glucose 55 mg%, Chlo-
ride 720 mg%. C.S.F. Lithium absent. 
RBC Lithium = 0.7 m Eq/L. Serum 
Lithium 1.6 m Eq/L, giving a lithium 
ratio of 0.44. 
Over the next three days, the patient's 
condition remained status quo. Lithium 
was withdrawn and plenty of oral fluids 
given. He was on no other medication. 
His sensorium improved over the next one 
week and by the 10th day of admission, 
it was quite clear. He continued to have 
mild tremors of the hand and dysarthric 
speech. By the end of second week, the 
muscle power was normal. Tremors of the 
hand and cerebellar signs were mild, but 
the speech was disproportionately dysarthric. 
He could not recall when he came to the 
hospital, and was amnestic to the first four 
days of hospital stay and the two days prior 
to this. As the patient was now euthymic, 
he was discharged without any medication 
and was advised to come for follow up 
every month. During the follow up, his 
dysarthric speech improved, but there was 
no total recovery although muscle power 
was normal and tremors had totally sub-
sided. 
He was admitted again in January 
1980 for mania and was treated with 
phenothiazines. His neurological status, 
but for the residual dysarthria, was normal. 
DISCUSSION 
Neuroleptic medication like chlorpro-
mazine or haloperidol administered along 
with lithium can possibly increase the 
toxicity of lithium (Refkin et al., 1973). 306  G. SAMPATH et a\ 
Evidence to such a possibility exists in the 
reports of Cohen and Cohen (1974). Elderly 
patients possibly (Van Der Velde, 1971) 
as also schizophrenics (Shopshin et al., 
1970) do not tolerate lithium well. Low 
sodium intake and excessive loss of sodium 
can lead to lithium retention and toxicity 
(Platman & Fieve, 1969). Increased 
intra-cellular lithium levels have been pos-
tulated as leading to lithium toxicity (Elizur 
et ah, 1972). It is clear that none of these 
usually possible explanations are appli-
cable in our patient. 
Intercurrent infections, especially very 
mild ones, are very difficult to rule out. 
But the blood counts do not indicate the 
presence of infection, and a normal C.S.F. 
makes an encephalitis highly unlikely. We 
are hence unable to explain this toxicity 
at therapeutic serum levels. 
The fact that a rare patient who even 
when fairly stable on lithium can develop 
toxicity for as yet unknown reasons, makes 
it necessary for us to consider this new 
element of risk when considering lithium for 
therapy or for prophylaxis. 
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